These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 37900127)
1. Research progress on moyamoya disease combined with thyroid diseases. Zhang G; Liu E; Tan X; Liu C; Yang S Front Endocrinol (Lausanne); 2023; 14():1233567. PubMed ID: 37900127 [TBL] [Abstract][Full Text] [Related]
2. A case of Moyamoya disease in a girl with thyrotoxicosis. Lee R; Sung K; Park YM; Yu JJ; Koh YC; Chung S Yonsei Med J; 2009 Aug; 50(4):594-8. PubMed ID: 19718414 [TBL] [Abstract][Full Text] [Related]
3. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Liao X; Deng J; Dai W; Zhang T; Yan J Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161 [TBL] [Abstract][Full Text] [Related]
4. An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues. Kim JE; Jeon JS Neurol Res; 2014 May; 36(5):407-16. PubMed ID: 24641716 [TBL] [Abstract][Full Text] [Related]
5. A nationwide survey on unilateral moyamoya disease in Japan. Hayashi K; Horie N; Izumo T; Nagata I Clin Neurol Neurosurg; 2014 Sep; 124():1-5. PubMed ID: 24976021 [TBL] [Abstract][Full Text] [Related]
6. Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease. Kim JY; Kim BS; Kang JH Int J Cardiol; 2001 Aug; 80(1):101-3. PubMed ID: 11575263 [TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease. Chen JB; Liu Y; Zhou LX; Sun H; He M; You C J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790 [TBL] [Abstract][Full Text] [Related]
8. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. Im SH; Oh CW; Kwon OK; Kim JE; Han DH J Neurosurg; 2005 Jun; 102(6):1013-7. PubMed ID: 16028759 [TBL] [Abstract][Full Text] [Related]
9. Nationwide survey on quasi-moyamoya disease in Japan. Hayashi K; Horie N; Izumo T; Nagata I Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994 [TBL] [Abstract][Full Text] [Related]
10. Abnormal Embryonic Development of Cerebral Arteries as a Potential Cause of Moyamoya Disease. Tan C; Niu H; Duan R; Shi G; Zhao Y; Chen X; Ye X; Wang R World Neurosurg; 2019 Sep; 129():e224-e232. PubMed ID: 31125778 [TBL] [Abstract][Full Text] [Related]
11. Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review. Rallo MS; Akel O; Gurram A; Sun H Neurosurg Focus; 2021 Sep; 51(3):E5. PubMed ID: 34469865 [TBL] [Abstract][Full Text] [Related]
12. Progress on Complications of Direct Bypass for Moyamoya Disease. Yu J; Shi L; Guo Y; Xu B; Xu K Int J Med Sci; 2016; 13(8):578-87. PubMed ID: 27499690 [TBL] [Abstract][Full Text] [Related]
13. Research progress of moyamoya disease combined with renovascular hypertension. Liu E; Zhao H; Liu C; Tan X; Luo C; Yang S Front Surg; 2022; 9():969090. PubMed ID: 36090342 [TBL] [Abstract][Full Text] [Related]
14. Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review. Nakamura H; Sato K; Yoshimura S; Hayashi Y; Izumo T; Tokunaga Y J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105414. PubMed ID: 33130479 [TBL] [Abstract][Full Text] [Related]